1663Tip CYP11A1 Inhibitor Opevesostat (MK-5684) Alone or in Combination with Other Therapies for Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (mcrpc): the Phase I/II MK-5684-01A Substudy
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要